Identification of a deubiquitinating enzyme subfamily as substrates of the von Hippel-Lindau tumor suppressor

Biochemical and Biophysical Research Communications

Volumn 294, Issue 3, 2002, Pages 700-709

  Li, Zaibo ^a   Wang, Dakun ^a   Na, Xi ^a   Schoen, Susan R ^a   Messing, Edward M ^a   Wu, Guan ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; DEUBIQUITINATING ENZYME; ENZYME; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ARTICLE; CANCER INHIBITION; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DNA SEQUENCE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN MOTIF; SEQUENCE HOMOLOGY; VON HIPPEL LINDAU DISEASE;

AMINO ACID SEQUENCE; ANIMALS; CATALYSIS; COS CELLS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOPEPTIDASES; HIPPEL-LINDAU DISEASE; HUMANS; LIGASES; MOLECULAR SEQUENCE DATA; PLASMIDS; SEQUENCE ALIGNMENT; SUBSTRATE SPECIFICITY; TRANSFECTION; TUMOR SUPPRESSOR PROTEINS; UBIQUITIN-PROTEIN LIGASES; VON HIPPEL-LINDAU TUMOR SUPPRESSOR PROTEIN;

EID: 0036290499     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(02)00534-X     Document Type: Article

References (32)

1. Ubiquitin-dependent protein degradation
2. Ubiquitin, proteasomes, and the regulation of intracellular protein degradation
3. Ubiquitination and deubiquitination: Targeting of proteins for degradation by the proteasome
4. Deubiquitinating enzymes: A new class of biological regulators
5. Deubiquitinating enzymes: Their diversity and emerging roles
6. von Hippel-Lindau disease
7. Identification of the von Hippel-Lindau disease tumor suppressor gene
8. The von Hippel-Lindau tumor suppressor gene
9. Improved detection of germline mutations in the von Hippel-Lindau disease tumor suppressor gene
10. Mutations of the VHL tumour suppressor gene in renal carcinoma
11. Somatic mutations of the von Hippel-Lindau disease tumour suppressor gene in non-familial clear cell renal carcinoma
12. Frequent somatic mutations and loss of heterozygosity of the von Hippel-Lindau tumor suppressor gene in primary human renal cell carcinomas
13. The von Hippel-Lindau tumor-suppressor gene product forms a stable complex with human CUL-2 a member of the Cdc53 family of proteins
14. Activation of HIF1alpha ubiquitination by a reconstituted von Hippel-Lindau VHL tumor suppressor complex
15. Reconstitution of G1 cyclin ubiquitination with complexes containing SCFGrr1 and Rbx1
16. Identification of the von Hippel-lindau tumor-suppressor protein as part of an active E3 ubiquitin ligase complex
17. The von Hippel-Lindau tumor suppressor protein is a component of an E3 ubiquitin-protein ligase activity
18. VHL: Avery hip ligase
19. Structure of the VHL-ElonginC-ElonginB complex: Implications for VHL tumor suppressor function
20. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
21. Hypoxia inducible factor-alpha binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein
22. Ubiquitination of hypoxia-inducible factor requires direct binding to the beta-domain of the von Hippel-Lindau protein
23. Mechanism of regulation of the hypoxia-inducible factor-1 alpha by the von Hippel-Lindau tumor suppressor protein
24. Activation of HIF1alpha ubiquitination by a reconstituted von Hippel-Lindau VHL tumor suppressor complex
25. HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: Implications for O2 sensing
26. Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation
27. Elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation
28. A conserved family of prolyl-4-hydroxylases that modify HIF
29. Dynamic, site-specific interaction of hypoxia-inducible factor-1alpha with the von Hippel-Lindau tumor suppressor protein
30. Ubiquitination of a novel deubiquitinating enzyme requires direct binding to von Hippel-Lindau tumor suppressor protein
31. Prediction of the coding sequences of unidentified human genes. XIII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro
32. Elongin BC complex prevents degradation of von Hippel-Lindau tumor suppressor gene products